{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:51:31Z","timestamp":1761587491800,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.intimp.2022.109296","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T23:08:33Z","timestamp":1664665713000},"page":"109296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Donor peritoneal-derived cells can attenuate graft-versus-host disease after MHC-incompatible bone marrow transplantation in mice"],"prefix":"10.1016","volume":"112","author":[{"given":"Zhigang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.intimp.2022.109296_b0005","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Longo","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109296_b0010","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: a retrospective observational study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.intimp.2022.109296_b0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn","year":"2007","journal-title":"Orphanet. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.109296_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4110\/in.2011.11.1.68","article-title":"Effects of pre-conditioning dose on the immune kinetics and cytokine production in the leukocytes infiltrating GVHD tissues after MHC-matched transplantation","volume":"11","author":"Choi","year":"2011","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.intimp.2022.109296_b0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.intimp.2022.109296_b0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109296_b0035","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.21873\/anticanres.11483","article-title":"Acute graft versus host disease: a comprehensive review","volume":"37","author":"Nassereddine","year":"2017","journal-title":"Anticancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2022.109296_b0040","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109296_b0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/j.seminoncol.2012.09.004","article-title":"Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation","volume":"39","author":"Bastien","year":"2012","journal-title":"Semin. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109296_b0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/imt.15.128","article-title":"Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations","volume":"8","author":"Nishihori","year":"2016","journal-title":"Immunotherapy."},{"issue":"12","key":"10.1016\/j.intimp.2022.109296_b0055","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.bbmt.2015.07.012","article-title":"Phase II study of nonmyeloablative allogeneic bone marrow transplantation for B cell lymphoma with post-transplantation rituximab and donor selection based first on non-HLA factors","volume":"21","author":"Kanakry","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.intimp.2022.109296_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.693105","article-title":"The Yin and Yang of type 1 regulatory T cells: from discovery to clinical application","volume":"12","author":"Sayitoglu","year":"2021","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2022.109296_b0065","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1182\/blood-2013-10-525873","article-title":"Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice","volume":"124","author":"Ganguly","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2022.109296_b0070","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2022.109296_b0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12185-015-1915-9","article-title":"Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II\/III study","volume":"103","author":"Muroi","year":"2016","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109296_b0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2022.109296_b0085","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109296_b0090","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-beta: a master of all T cell trades","volume":"134","author":"Li","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2022.109296_b0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109296_b0100","doi-asserted-by":"crossref","first-page":"155077","DOI":"10.1016\/j.cyto.2020.155077","article-title":"The mechanism of Tyk2 deficiency-induced immunosuppression in mice involves robust IL-10 production in macrophages","volume":"130","author":"Hirashima","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2022.109296_b0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer","volume":"1183","author":"DiLillo","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2022.109296_b0110","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","article-title":"Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells","volume":"186","author":"Carter","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109296_b0115","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2010.01.018","article-title":"Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model","volume":"125","author":"Amu","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109296_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.790564","article-title":"CpG-activated regulatory B-cell progenitors alleviate murine graft-versus-host-disease","volume":"13","author":"Agbogan","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109296_b0125","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1073\/pnas.0915000107","article-title":"Two physically, functionally, and developmentally distinct peritoneal macrophage subsets","volume":"107","author":"Ghosn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.intimp.2022.109296_b0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","article-title":"Tissue-resident macrophage ontogeny and homeostasis","volume":"44","author":"Ginhoux","year":"2016","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.intimp.2022.109296_b0135","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1182\/blood-2013-01-478206","article-title":"Local apoptosis mediates clearance of macrophages from resolving inflammation in mice","volume":"122","author":"Gautier","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2022.109296_b0140","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2014-03-562710","article-title":"Resolution of acute inflammation bridges the gap between innate and adaptive immunity","volume":"124","author":"Newson","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2022.109296_b0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/cdd.2016.159","article-title":"CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages","volume":"24","author":"Murphy","year":"2017","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.intimp.2022.109296_b0150","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cell.2014.04.016","article-title":"Tissue-specific signals control reversible program of localization and functional polarization of macrophages","volume":"157","author":"Okabe","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2022.109296_b0155","article-title":"Treatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cells","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2022.109296_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.mcb.2021.12.008","article-title":"Mouse models of graft-versus-host disease","volume":"168","author":"Patel","year":"2022","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.intimp.2022.109296_b0165","article-title":"Isolation of mouse peritoneal cavity cells","volume":"35","author":"Ray","year":"2010","journal-title":"J Vis Exp."},{"issue":"8","key":"10.1016\/j.intimp.2022.109296_b0170","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2022.109296_b0175","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.4049\/jimmunol.173.9.5467","article-title":"Target antigens determine graft-versus-host disease phenotype","volume":"173","author":"Kaplan","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109296_b0180","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.intimp.2022.109296_b0185","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2007-11-125294","article-title":"CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL","volume":"111","author":"Matte-Martone","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2022.109296_b0190","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/stem.2759","article-title":"Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal\/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations","volume":"36","author":"Fujii","year":"2018","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.intimp.2022.109296_b0195","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1182\/blood-2006-04-016410","article-title":"Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse","volume":"109","author":"Chen","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2022.109296_b0200","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109296_b0205","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.bbmt.2020.08.034","article-title":"Clinical-grade expanded regulatory T cells are enriched with highly suppressive cells producing IL-10, granzyme B, and IL-35","volume":"26","author":"Ulbar","year":"2020","journal-title":"Biol. Blood Marrow Transplant."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922007809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922007809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:46:56Z","timestamp":1761587216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922007809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":41,"alternative-id":["S1567576922007809"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109296","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor peritoneal-derived cells can attenuate graft-versus-host disease after MHC-incompatible bone marrow transplantation in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109296"}}